Psychopharmacology 2025

9 papers
The 2025 edition of Psychopharmacology featured nine papers emphasizing the transition from preclinical models to clinical applications. Key research directions included the temporal decomposition of neural reward processing, the use of Mendelian Randomization for causal inference, and the differentiation between neural and vascular drivers in hemodynamic signaling. Methodological rigor was a central theme, with studies addressing antidepressant onset efficacy and the analysis of pooled clinical data to identify predictors of weight gain during olanzapine treatment. Prolific contributors for the year included Ilya Lipkovich, Fan Li, and Charles M. Beasley. Experimental research investigated diverse interventions, such as the GPR139 agonist TAK-041 for schizophrenia and brain-computer interface programs for ADHD. Several studies explored the therapeutic potential of specific compounds, including Xanthouhumol for stress-induced depression and Rosmarinic acid for autism-like phenotypes. Additional work examined the neuroprotective effects of oxiracetam following traumatic brain injury and gender-based differences in the neural correlates of emotional memory. Collectively, these publications focused on refining therapeutic targets and improving the precision of psychiatric treatments through both molecular and methodological advancements.

Top Research Directions

The 4 research directions with Psychopharmacology 2025 papers, ranked by paper count. Share is the fraction of the edition’s papers in the direction.

#DirectionPapersShare
1Isolating Independent Effects with Multivariate Covariate Adjustment111.1%
2Overcoming the Limitations of Monoaminergic Antidepressants111.1%
3Pharmacological Confounding in Clinical Biomarker Research111.1%
4Restoring Neural Sensitivity to Everyday Rewards111.1%

Download all directions as CSV

Institutions

Institutions credited by Psychopharmacology 2025 papers: a paper credits every institution named in its affiliations, once. 8 institutions share 2 credited papers.

#InstitutionPapersShare
101qz7fr76 150.0%
20288swk05 150.0%
3BI Norwegian Business School 150.0%
4Jagiellonian University 150.0%
5King's College London 150.0%
6Poznań University of Technology 150.0%
7Takeda (Japan) 150.0%
8University of Sussex 150.0%

Download all institutions as CSV

About this data

Papers. Psychopharmacology 2025 lists 9 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 2 of 9 papers (22.2%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-17 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “Psychopharmacology 2025”, https://lacuna.tiptreesystems.com/venue/psychopharmacology/2025.

Top Authors

AuthorPapers
Ilya Lipkovich2
Cuntai Guan1
Sam Gijsen1
Weidong Zhao1

Papers

Title
Addressing Methodological Issues in Studying Antidepressant Onset Efficacy Using Prespecified Sensitivity Analyses
Early Predictors of Weight Gain Risk During Treatment with Olanzapine:Analysis of Pooled Data from 58 Clinical Trials
Effectiveness of a Brain-Computer Interface Based Programme for the Treatment of ADHD: A Pilot Study
Gender Differences in Cognitive and Neural Correlates of Remembrance of Emotional Words
Oxiracetam ameliorates neurological function after traumatic brain injury through competing endogenous RNA regulatory network
Targeting synaptic plasticity and acetylcholine dysregulation in the medial prefrontal cortex: Rosmarinic acid attenuates Autism-like phenotypes in Shank3B−/− mice via the CREB/BDNF pathway
The GPR139 agonist TAK-041 produces time-dependent alterations to cerebral blood flow and reward system function in patients with schizophrenia: a randomised placebo-controlled trial
The link between tobacco smoking and susceptibility to misinformation
Xanthouhumol relieves stress-induced depressive-like behaviors through the Sirt1/NF-κB/NLRP3 pathway